Paper Details
- Home
- Paper Details
Inhibition of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder tumor in rats by alpha-difluoromethylornithine.
Author: KawaharaM, MatsuhashiT, MatsushimaM, TajimaM, YagishitaT
Original Abstract of the Article :
The therapeutic effects of alpha-difluoromethylornithine (DFMO) on rats with bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) were examined. Eight-week-old male Wistar rats were given 0.05% BBN in their drinking water for a period of 4 weeks. Therapy (0.1% DFMO in their drinkin...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/3107357
データ提供:米国国立医学図書館(NLM)
Alpha-Difluoromethylornithine's Effects on Bladder Tumors
This study takes us on a journey through the vast desert of [oncology], exploring the potential of [alpha-difluoromethylornithine (DFMO)] to inhibit [bladder tumor] growth in rats. It's like discovering a new plant in the desert that could potentially help combat a disease. The researchers investigated the effects of [DFMO] on rats with [bladder tumors] induced by [N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)]. They found that [DFMO] significantly reduced the [incidence], [number], and [size] of [bladder tumors] in this model. This discovery suggests that [DFMO] may have potential as a therapeutic agent for treating [bladder cancer].DFMO Shows Promise in Inhibiting Bladder Tumor Growth
This study provides encouraging evidence for the potential of [DFMO] as a treatment for [bladder cancer]. They found that [specify the main findings]. This discovery could pave the way for new and more effective treatment options for patients with [bladder cancer].Navigating the Desert of Bladder Cancer Treatment
This study helps us navigate the desert of [bladder cancer] treatment by highlighting the potential of [DFMO] as a promising therapeutic agent. It's important to remember that every case of [bladder cancer] is unique, like a unique sand dune in a vast desert. This study provides valuable insights into the potential of [DFMO] to inhibit [bladder tumor] growth and encourages further research to fully explore its potential for treating [bladder cancer].Dr.Camel's Conclusion
This study offers promising insights into the potential of [alpha-difluoromethylornithine (DFMO)] as a therapeutic agent for treating [bladder cancer]. The researchers demonstrated that [DFMO] effectively reduced the [incidence], [number], and [size] of [bladder tumors] in rats. This discovery warrants further investigation into the potential of [DFMO] for treating [bladder cancer] in humans and could contribute to the development of new and more effective treatment options for this challenging disease.Date :
- Date Completed 1987-06-08
- Date Revised 2013-11-21
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.